Despite representing a small proportion of tumour-specific CD8+ T cells, selective deletion of tumour-specific Tcf7+ CD8+ T cells accelerates tumour growth and diminishes response to ICB in mouse models [69]. The gene discussed is CD8A; the disease is neoplasm.